Your browser doesn't support javascript.
loading
Otitis media susceptibility and shifts in the head and neck microbiome due to SPINK5 variants.
Frank, Daniel N; Giese, Arnaud P J; Hafren, Lena; Bootpetch, Tori C; Yarza, Talitha Karisse L; Steritz, Matthew J; Pedro, Melquiadesa; Labra, Patrick John; Daly, Kathleen A; Tantoco, Ma Leah C; Szeremeta, Wasyl; Reyes-Quintos, Maria Rina T; Ahankoob, Niaz; Llanes, Erasmo Gonzalo D V; Pine, Harold S; Yousaf, Sairah; Ir, Diana; Einarsdottir, Elisabet; de la Cruz, Rhodieleen Anne R; Lee, Nanette R; Nonato, Rachelle Marie A; Robertson, Charles E; Ong, Kimberly Mae C; Magno, Jose Pedrito M; Chiong, Alessandra Nadine E; Espiritu-Chiong, Ma Carmina; San Agustin, Maria Luz; Cruz, Teresa Luisa G; Abes, Generoso T; Bamshad, Michael J; Cutiongco-de la Paz, Eva Maria; Kere, Juha; Nickerson, Deborah A; Mohlke, Karen L; Riazuddin, Saima; Chan, Abner; Mattila, Petri S; Leal, Suzanne M; Ryan, Allen F; Ahmed, Zubair M; Chonmaitree, Tasnee; Sale, Michele M; Chiong, Charlotte M; Santos-Cortez, Regie Lyn P.
Afiliação
  • Frank DN; Department of Medicine, Division of Infectious Diseases, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
  • Giese APJ; Department of Otorhinolaryngology, Head and Neck Surgery, University of Maryland, Baltimore, Maryland, USA.
  • Hafren L; Department of Otorhinolaryngology, Head & Neck Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Bootpetch TC; Department of Otolaryngology-Head and Neck Surgery, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
  • Yarza TKL; Philippine National Ear Institute, University of the Philippines Manila - National Institutes of Health, Manila, Philippines.
  • Steritz MJ; Newborn Hearing Screening Reference Center, University of the Philippines Manila - National Institutes of Health, Manila, Philippines.
  • Pedro M; Department of Otolaryngology-Head and Neck Surgery, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
  • Labra PJ; Philippine National Ear Institute, University of the Philippines Manila - National Institutes of Health, Manila, Philippines.
  • Daly KA; Philippine National Ear Institute, University of the Philippines Manila - National Institutes of Health, Manila, Philippines.
  • Tantoco MLC; Department of Otolaryngology, Head and Neck Surgery, University of Minnesota, Minneapolis, Minnesota, USA.
  • Szeremeta W; Philippine National Ear Institute, University of the Philippines Manila - National Institutes of Health, Manila, Philippines.
  • Reyes-Quintos MRT; Newborn Hearing Screening Reference Center, University of the Philippines Manila - National Institutes of Health, Manila, Philippines.
  • Ahankoob N; Department of Otorhinolaryngology, Philippine General Hospital, Manila, Philippines.
  • Llanes EGDV; Department of Otolaryngology, University of Texas Medical Branch at Galveston, Galveston, Texas, USA.
  • Pine HS; Philippine National Ear Institute, University of the Philippines Manila - National Institutes of Health, Manila, Philippines.
  • Yousaf S; Newborn Hearing Screening Reference Center, University of the Philippines Manila - National Institutes of Health, Manila, Philippines.
  • Ir D; Department of Otorhinolaryngology, Philippine General Hospital, Manila, Philippines.
  • Einarsdottir E; National Institutes of Health, University of the Philippines Manila, Manila, Philippines.
  • de la Cruz RAR; Department of Otolaryngology-Head and Neck Surgery, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
  • Lee NR; Philippine National Ear Institute, University of the Philippines Manila - National Institutes of Health, Manila, Philippines.
  • Nonato RMA; Newborn Hearing Screening Reference Center, University of the Philippines Manila - National Institutes of Health, Manila, Philippines.
  • Robertson CE; Department of Otorhinolaryngology, Philippine General Hospital, Manila, Philippines.
  • Ong KMC; Department of Otolaryngology, University of Texas Medical Branch at Galveston, Galveston, Texas, USA.
  • Magno JPM; Department of Otorhinolaryngology, Head and Neck Surgery, University of Maryland, Baltimore, Maryland, USA.
  • Chiong ANE; Department of Medicine, Division of Infectious Diseases, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
  • Espiritu-Chiong MC; Folkhälsan Institute of Genetics, University of Helsinki, Helsinki, Finland.
  • San Agustin ML; Molecular Neurology Research Program, University of Helsinki, Helsinki, Finland.
  • Cruz TLG; Department of Otorhinolaryngology, Philippine General Hospital, Manila, Philippines.
  • Abes GT; Department of Anthropology, Sociology and History, University of San Carlos, Cebu City, Philippines.
  • Bamshad MJ; Department of Otorhinolaryngology, Philippine General Hospital, Manila, Philippines.
  • Cutiongco-de la Paz EM; Department of Medicine, Division of Infectious Diseases, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
  • Kere J; Department of Otorhinolaryngology, Philippine General Hospital, Manila, Philippines.
  • Nickerson DA; Department of Otorhinolaryngology, Philippine General Hospital, Manila, Philippines.
  • Mohlke KL; Philippine National Ear Institute, University of the Philippines Manila - National Institutes of Health, Manila, Philippines.
  • Riazuddin S; Department of Otorhinolaryngology, Philippine General Hospital, Manila, Philippines.
  • Chan A; Renergy Dermatology & Laser Center, Taguig City, Philippines.
  • Mattila PS; Philippine National Ear Institute, University of the Philippines Manila - National Institutes of Health, Manila, Philippines.
  • Leal SM; Department of Otorhinolaryngology, Philippine General Hospital, Manila, Philippines.
  • Ryan AF; Philippine National Ear Institute, University of the Philippines Manila - National Institutes of Health, Manila, Philippines.
  • Ahmed ZM; Department of Otorhinolaryngology, Philippine General Hospital, Manila, Philippines.
  • Chonmaitree T; Philippine National Ear Institute, University of the Philippines Manila - National Institutes of Health, Manila, Philippines.
  • Sale MM; Department of Otorhinolaryngology, Philippine General Hospital, Manila, Philippines.
  • Chiong CM; Department of Genome Sciences, University of Washington, Seattle, Washington, USA.
  • Santos-Cortez RLP; National Institutes of Health, University of the Philippines Manila, Manila, Philippines.
J Med Genet ; 58(7): 442-452, 2021 07.
Article em En | MEDLINE | ID: mdl-32709676
ABSTRACT

BACKGROUND:

Otitis media (OM) susceptibility has significant heritability; however, the role of rare variants in OM is mostly unknown. Our goal is to identify novel rare variants that confer OM susceptibility.

METHODS:

We performed exome and Sanger sequencing of >1000 DNA samples from 551 multiethnic families with OM and unrelated individuals, RNA-sequencing and microbiome sequencing and analyses of swabs from the outer ear, middle ear, nasopharynx and oral cavity. We also examined protein localisation and gene expression in infected and healthy middle ear tissues.

RESULTS:

A large, intermarried pedigree that includes 81 OM-affected and 53 unaffected individuals cosegregates two known rare A2ML1 variants, a common FUT2 variant and a rare, novel pathogenic variant c.1682A>G (p.Glu561Gly) within SPINK5 (LOD=4.09). Carriage of the SPINK5 missense variant resulted in increased relative abundance of Microbacteriaceae in the middle ear, along with occurrence of Microbacteriaceae in the outer ear and oral cavity but not the nasopharynx. Eight additional novel SPINK5 variants were identified in 12 families and individuals with OM. A role for SPINK5 in OM susceptibility is further supported by lower RNA counts in variant carriers, strong SPINK5 localisation in outer ear skin, faint localisation to middle ear mucosa and eardrum and increased SPINK5 expression in human cholesteatoma.

CONCLUSION:

SPINK5 variants confer susceptibility to non-syndromic OM. These variants potentially contribute to middle ear pathology through breakdown of mucosal and epithelial barriers, immunodeficiency such as poor vaccination response, alteration of head and neck microbiota and facilitation of entry of opportunistic pathogens into the middle ear.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Otite Média / Microbiota / Inibidor de Serinopeptidase do Tipo Kazal 5 Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Otite Média / Microbiota / Inibidor de Serinopeptidase do Tipo Kazal 5 Idioma: En Ano de publicação: 2021 Tipo de documento: Article